newsfilter
← Latest News
GlobeNewswire·

Novan Reports First Quarter 2022 Financial Results and Provides Corporate Update

– Transformational quarter for Novan, marked by acquisition of EPI Health – – Strongest quarter in total prescriptions for Rhofade increasing 47% from Q1 2021 – – Ongoing activities toward submission of first New Drug Application (NDA) f